Skip to main content

Table 1 Patient clinical characteristics and detection level of F. nucleatum

From: Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma

Clinical
Characteristic
Total Number of Patients Total
Detect Number
Samples for detect F. nucleatum
(N = 98)
Positive Negative P-value
111 98 68(69.4%) 30(29.6%)
Age (mean, range)
62.9 ± 7.1
  < 60 31(27.9%) 29 22(75.9%) 7(24.1%) 0.1412
  > 60 80(72.7%) 69 46(66.7%) 23(33.3%)  
Gender
 Male 64(57.7%) 56 39(69.6%) 17(30.4%) 0.9989
 Female 47(42.3%) 42 29(69%) 13(31%)  
Smoking
 Yes 44(39.6%) 39 26(66.7%) 13(33.3%) 0.9428
 No 67(60.4%) 59 42(71.2%) 17(28.8%)  
Drinking
 Yes 46(41.4%) 39 25(64.1%) 14(35.9%) 0.5561
 No 65(58.6%) 59 43(72.9%) 16(28.8%)  
Histopathological grading
 G1–2 79(71.2%) 72 50(69.4%) 22(30.6%) 0.5305
 G3 32(28.8%) 26 18(69.2%) 8(30.8%)  
clinical T stage (pT)
 pT1–2 44(39.6%) 35 24(68.6%) 11(31.4%) 0.039
 pT3–4 67(60.4%) 63 44(69.8%) 19(30.2%)  
lymph node
 pN0–1 97(87.4%) 89 61(68.5%) 28(31.5%) 0.1343
 pN2–3 14(12.6%) 9 7(77.8%) 2(22.2%)  
Clinical tumor stage
 I 8(7.2%) 4 3(75%) 1(25%) 0.0033
 II 71(64%) 68 44(64.7%) 24(35.3%)  
 III 32(28.8%) 26 21(84%) 5(15.4%)